Colorectal Carcinoma
|
0.300 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Lip and Oral Cavity Carcinoma
|
0.110 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Oral lesion
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
|
|
|
Developmental Disabilities
|
0.300 |
Biomarker
|
group |
CTD_human |
Disruption of contactin 4 (CNTN4) results in developmental delay and other features of 3p deletion syndrome.
|
15106122 |
2004 |
Growth Disorders
|
0.300 |
Biomarker
|
group |
CTD_human |
Disruption of contactin 4 (CNTN4) results in developmental delay and other features of 3p deletion syndrome.
|
15106122 |
2004 |
Child Development Deviations
|
0.300 |
Biomarker
|
disease |
CTD_human |
Disruption of contactin 4 (CNTN4) results in developmental delay and other features of 3p deletion syndrome.
|
15106122 |
2004 |
Child Development Disorders, Specific
|
0.300 |
Biomarker
|
disease |
CTD_human |
Disruption of contactin 4 (CNTN4) results in developmental delay and other features of 3p deletion syndrome.
|
15106122 |
2004 |
Craniofacial Abnormalities
|
0.300 |
Biomarker
|
group |
CTD_human |
Disruption of contactin 4 (CNTN4) results in developmental delay and other features of 3p deletion syndrome.
|
15106122 |
2004 |
Muscular fasciculation
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
This transcript (also known as BIG-2) is a member of the immunoglobulin super family of neuronal cell adhesion molecules involved in axon growth, guidance, and fasciculation in the central nervous system (CNS).
|
15106122 |
2004 |
Developmental delay (disorder)
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Disruption of contactin 4 (CNTN4) results in developmental delay and other features of 3p deletion syndrome.
|
15106122 |
2004 |
Global developmental delay
|
0.010 |
Biomarker
|
disease |
BEFREE |
Disruption of contactin 4 (CNTN4) results in developmental delay and other features of 3p deletion syndrome.
|
15106122 |
2004 |
Ataxia, Spinocerebellar
|
0.020 |
Biomarker
|
disease |
LHGDN |
The contactin 4 gene locus at 3p26 is a candidate gene of SCA16.
|
17030759 |
2006 |
Cerebellar degeneration
|
0.010 |
Biomarker
|
disease |
BEFREE |
The contactin 4 gene (CNTN4) is associated with cerebellar degeneration in spinocerebellar ataxia type 16.
|
17030759 |
2006 |
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16
|
0.010 |
Biomarker
|
disease |
BEFREE |
The contactin 4 gene (CNTN4) is associated with cerebellar degeneration in spinocerebellar ataxia type 16.
|
17030759 |
2006 |
Intellectual Disability
|
0.030 |
Biomarker
|
group |
BEFREE |
FISH and array-CGH analysis of a complex chromosome 3 aberration suggests that loss of CNTN4 and CRBN contributes to mental retardation in 3pter deletions.
|
17036314 |
2006 |
Mental Retardation
|
0.020 |
Biomarker
|
disease |
BEFREE |
FISH and array-CGH analysis of a complex chromosome 3 aberration suggests that loss of CNTN4 and CRBN contributes to mental retardation in 3pter deletions.
|
17036314 |
2006 |
Distal monosomy 3p syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
We suggest that 3p- syndrome associated features are primarily caused by loss of CNTN4 and CRBN, with loss of CHL1 probably having an additional detrimental effect on the cognitive functioning of the present patient.
|
17036314 |
2006 |
Ataxia, Spinocerebellar
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
The CNTN4 c.4256C>T mutation is rare in Japanese with inherited spinocerebellar ataxia.
|
17915252 |
2008 |
Autistic Disorder
|
0.340 |
GeneticVariation
|
disease |
BEFREE |
We focused our initial analysis on CNTNAP2 based on our demonstration of disruption of Contactin 4 (CNTN4) in a patient with ASD; the recent finding of rare homozygous mutations in CNTNAP2 leading to intractable seizures and autism; and in situ and biochemical analyses reported herein that confirm expression in relevant brain regions and demonstrate the presence of CNTNAP2 in the synaptic plasma membrane fraction of rat forebrain lysates.
|
18179895 |
2008 |
Autism Spectrum Disorders
|
0.070 |
GeneticVariation
|
disease |
BEFREE |
We focused our initial analysis on CNTNAP2 based on our demonstration of disruption of Contactin 4 (CNTN4) in a patient with ASD; the recent finding of rare homozygous mutations in CNTNAP2 leading to intractable seizures and autism; and in situ and biochemical analyses reported herein that confirm expression in relevant brain regions and demonstrate the presence of CNTNAP2 in the synaptic plasma membrane fraction of rat forebrain lysates.
|
18179895 |
2008 |
Seizures
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
We focused our initial analysis on CNTNAP2 based on our demonstration of disruption of Contactin 4 (CNTN4) in a patient with ASD; the recent finding of rare homozygous mutations in CNTNAP2 leading to intractable seizures and autism; and in situ and biochemical analyses reported herein that confirm expression in relevant brain regions and demonstrate the presence of CNTNAP2 in the synaptic plasma membrane fraction of rat forebrain lysates.
|
18179895 |
2008 |
Autistic Disorder
|
0.340 |
Biomarker
|
disease |
CTD_human |
Disruption of contactin 4 in three subjects with autism spectrum disorder.
|
18349135 |
2009 |
Autism Spectrum Disorders
|
0.070 |
Biomarker
|
disease |
BEFREE |
Disruption of contactin 4 in three subjects with autism spectrum disorder.
|
18349135 |
2009 |
Pervasive Development Disorder
|
0.010 |
Biomarker
|
group |
BEFREE |
Disruption of contactin 4 in three subjects with autism spectrum disorder.
|
18349135 |
2009 |
Autism Spectrum Disorders
|
0.070 |
GeneticVariation
|
disease |
BEFREE |
10) and CNTN4 (refs 11, 12), several new susceptibility genes encoding neuronal cell-adhesion molecules, including NLGN1 and ASTN2, were enriched with CNVs in ASD cases compared to controls (P = 9.5 x 10(-3)).
|
19404257 |
2009 |